- The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
- Keep up to date with cardiology: Access the latest cardiovascular medicine resources from across BMJ Group.
- Our online table of contents is updated at least twice each day. Read all articles published in the last 7 days.
- OPEN ACCESS: All research articles are freely available online, with no word limit. Find out more about the BMJ's open access policy. Submit your paper.
Blood clots and artery blockage more likely during IVF pregnancies
Risk of blockage lower but still leading cause of maternal deaths
In vitro fertilization (IVF) is associated with an increased risk of pulmonary embolism (blockage of the main artery of the lung) and venous thromboembolism (blood clots) during the first trimester of pregnancy, a study published today on bmj.com suggests.
IVF has been used since 1978 for the 10% of couples worldwide affected by infertility. Approximately five million individuals have so far been born after IVF.
It is well known that the risk of blood clots is increased during normal pregnancy, affecting around one in 1000 in the early 1990s.
Blood clots have been reported in more IVF pregnancies than normal pregnancies, but so far there is no information on the risk of artery blockage following IVF, which is important since this is a leading cause of maternal deaths.
Researchers from the Karolinska Institute in Sweden therefore compared the risk of both pulmonary embolism (PE) and venous thromboembolism (VTE) in women undergoing an IVF pregnancy (23,498) and women undergoing normal pregnancy (116,960). Women were matched for age and time period (births between 1990 and 2008). The women had an average age of 33 for both groups.
The proportion of IVF women who were diagnosed with VTE was 4.2 in 1000 compared with 2.5 in 1000 of the unexposed women. Risk was increased during the first trimester (1.5 in exposed and 0.3 in unexposed). There was no difference in risk prior to pregnancy or during the year after delivery.
Researchers identified 19 women with PE in the IVF group (0.08%) compared with 70 women in the unexposed group (0.05%). The risk of PE in the IVF women was increased during the whole pregnancy and particularly in the first trimester.
Absolute risks for PE were low however with 2-3 additional cases per 10,000 IVF women. However, the researchers say that PE is a difficult condition to diagnose and still represents a leading cause of maternal death and so these findings are important to physicians.
Results were not affected when adjustments were made for: maternal age, calendar years of delivery, BMI, parity, smoking, country of birth, family situation and education.
The researchers conclude that there is an increased risk of blood clots and importantly an increased risk of artery blockage in pregnancy after IVF. They say all physicians should be aware of these results as it is a potentially fatal condition and recommend that “efforts should focus on the identification of women at risk”.
Research: Professor Peter Henriksson, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Sweden